Provided by Tiger Fintech (Singapore) Pte. Ltd.

NLS Pharmaceutics Ltd.

2.86
-0.0400-1.38%
Post-market: 2.80-0.0600-2.10%17:46 EDT
Volume:475.71K
Turnover:1.40M
Market Cap:10.29M
PE:-0.43
High:3.03
Open:2.96
Low:2.76
Close:2.90
Loading ...

NLS Pharmaceutics AG Held Extraordinary Shareholders' Meeting

Reuters
·
1 hour ago

NLS Pharmaceutics AG Announces Fifth Amendment to Merger Agreement with Kadimastem Ltd

Reuters
·
1 hour ago

NLS Pharmaceutics Secures $1 Million Through Equity Financing Amendment

TIPRANKS
·
30 Jun

NLS Pharmaceutics AG Amends Securities Purchase Agreement to Facilitate Subsequent Closing

Reuters
·
30 Jun

BRIEF-Kadimastem - Total Proceeds From Equity Financing Reach $3 Million

Reuters
·
30 Jun

Kadimastem Ltd - Funds to Support Pending Merger With Kadimastem

THOMSON REUTERS
·
30 Jun

Kadimastem Ltd - Total Proceeds From Equity Financing Reach $3 Mln

THOMSON REUTERS
·
30 Jun

Press Release: NLS Pharmaceutics and Kadimastem Announce Pricing and Closing of $1 Million Equity Financing

Dow Jones
·
30 Jun

NLS Pharmaceutics Announces Strategic Merger and Financing Milestones

TIPRANKS
·
16 Jun

NLS Pharmaceutics AG Announces Imminent Merger with Kadimastem, Plans to Form NewcelX with Expanded Clinical Pipeline

Reuters
·
16 Jun

Press Release: NLS Pharmaceutics CEO Issues Letter to Shareholders

Dow Jones
·
16 Jun

NLS Pharmaceutics AG Announces Fourth Amendment to Merger Agreement with Kadimastem Ltd

Reuters
·
07 Jun

NLS Pharmaceutics to present new preclinical data on Mazindol ER at ASCP

TIPRANKS
·
21 May

NLS Pharmaceutics AG Reports Significant Decrease in Net Loss to $1.98M for 2024, Driven by Lower Operating Costs and Increased Other Income

Reuters
·
17 May

NLS Pharmaceutics Announces Board Resignation Amid Restructuring Efforts

TIPRANKS
·
25 Apr

NLS Pharmaceutics Study Suggests Mazindol May Help Treat Fentanyl Use Disorder

MT Newswires Live
·
15 Apr

NLS Pharmaceutics Reports Positive Results in Fentanyl Study

TIPRANKS
·
15 Apr

BRIEF-Nls Pharmaceutics Announces Positive Results From Study Ko-943 Demonstrating Mazindol Reduces Fentanyl-Induced Reward In Animal Models

Reuters
·
15 Apr

NLS Pharmaceutics’ Mazindol reduces fentanyl-induced reward in animal models

TIPRANKS
·
15 Apr

NLS Pharmaceutics Announces Positive Results From Study Ko-943 Demonstrating Mazindol Reduces Fentanyl-Induced Reward in Animal Models

THOMSON REUTERS
·
15 Apr